In this study, we report a BRONJ patient who was treated with surgical debridement, sequestrectomy, and simultaneous reconstruction using PRF as the sole grafting material.
A 79-year-old woman was referred in July 2011 by a local dental clinic for a painful jaw bone lesion. Her medical history included osteoporosis since 1996, which was treated weekly with alendronate (Fosamax, 70 mg, per os; Merck, Whitehouse Station, NJ, USA) for 10 more years, and intravenous zoledronic acid (Aclasta; Norvatis Pharmaceuticals, Frimley, Camberley, UK) infusions annually, at a dose of 5 mg, from 2010 to 2011. The intraoral examination revealed a diffuse, tender, erythematous swelling over the edentulous area at the right posterior mandible with a purulent discharge ( Figure 1A) . Panoramic tomography showed a sequestrum in the right posterior mandible ( Figure 1B ). According to the patient's clinical and radiological findings, the diagnosis was BRONJ stage 3. Medical therapy with ciprofloxacin (750 mg/d) and chlorhexidine mouthwashes were prescribed for 3 months. Then, the patient received surgical sequestrectomy and saucerization ( Figure 1C ) under general anesthesia with simultaneous reconstruction with PRF. PRF clots and membranes were prepared according to the Choukroun procedure.
1 PRF was packed into the surgical defect ( Figure 1D ). The overlying mucosa was sutured tension free with PRF membranes. After 10 days, postoperative healing was uneventful with no signs of infection or wound dehiscence ( Figure 1E ). Panoramic tomography showed new bone regeneration and no sign of necrotic bone after 10 months of follow-up ( Figure 1E ). The patient was still regularly followed up in our clinic. No new oral lesion was observed.
Recently, we reported that the use of PRF as sole filling material applied in simultaneous sinus lift and implantation demonstrated a new bone formation in the augmented areas. 2 In this case, the application of PRF for BRONJ also revealed total bone closure and new bone regeneration. The mechanism responsible for the osteoblasts by PRF may be explained as follows. Previously, PRF was found to be capable of increasing osteoblast attachment, growth, proliferation, and simultaneously upregulating osteoprotegerin and collagen-related protein production. 3e5 These actions in combination may effectively promote bone regeneration. Taken together, PRF could be an easily prepared and effective material for the closure of BRONJ. The 
